Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BORENSTEIN M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 39 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kane, JM; Marder, SR; Schooler, NR; Wirshing, WC; Umbricht, D; Baker, RW; Wirshing, DA; Safferman, A; Ganguli, R; McMeniman, M; Borenstein, M
      Clozapine and haloperidol in moderately refractory schizophrenia - A 6-month randomized and double-blind comparison

      ARCHIVES OF GENERAL PSYCHIATRY
    2. Aksoy, MO; Li, XX; Borenstein, M; Yi, Y; Kelsen, SG
      Effects of topical corticosteroids on inflammatory mediator-induced eicosanoid release by human airway epithelial cells

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    3. Borenstein, M
      Jacob Cohen, PhD, 1923-1998 - Obituary

      ARCHIVES OF GENERAL PSYCHIATRY
    4. KHANDELWAL M; REECE EA; WU YK; BORENSTEIN M
      DIETARY MYOINOSITOL THERAPY IN HYPERGLYCEMIA-INDUCED EMBRYOPATHY

      Teratology
    5. BORENSTEIN M
      HYPOTHESIS-TESTING AND EFFECT SIZE ESTIMATION IN CLINICAL-TRIALS

      Annals of allergy, asthma, & immunology
    6. GOLDMAN RS; BATES JA; PAPPADOPULOS E; BILDER RM; BORENSTEIN M; KANE J; SCHOOLER N; MARDER S
      EFFECTS OF CLOZAPINE AND HALOPERIDOL ON EXPLICIT MEMORY IN TREATMENT-REFRACTORY PATIENTS

      Schizophrenia research
    7. MARDER SR; KANE JM; SCHOOLER NR; WIRSHING WC; BAKER R; AMES D; UMBRICHT D; GANGULI R; BORENSTEIN M
      EFFECTIVENESS OF CLOZAPINE IN TREATMENT-RESISTANT SCHIZOPHRENIA

      Schizophrenia research
    8. SCHOOLER N; BORENSTEIN M; AMES D; BAKER R; UMBRICHT D; WIRSHING W; KANE J; MARDER S
      FIRST IMPROVEMENT WITH CLOZAPINE - HOW PATIENT SHOULD WE BE

      Schizophrenia research
    9. UMBRICHT D; AMES D; WIRSHING WC; BAKER R; CHENGAPPA R; BORENSTEIN M; SCHOOLER N; MARDER S; KANE J
      PREDICTORS OF RESPONSE TO CLOZAPINE IN A LONG-TERM DOUBLE-BLIND TREATMENT STUDY

      Schizophrenia research
    10. ROY MS; BORENSTEIN M
      RISK-FACTORS FOR DIABETIC-RETINOPATHY IN AFRICAN-AMERICANS WITH TYPE-I DIABETES - THE NEW-JERSEY STUDY

      Investigative ophthalmology & visual science
    11. BORENSTEIN M; ROTHSTEIN H; COHEN J
      POWER WITH CONFIDENCE

      Psychopharmacology bulletin
    12. BORENSTEIN M; SHUPAK R; BARNETTE R; COONEY G; JOHNSON W; TZENG TB
      CARDIOVASCULAR EFFECTS OF DIFFERENT INFUSION RATES OF SUFENTANIL IN PATIENTS UNDERGOING CORONARY SURGERY

      European Journal of Clinical Pharmacology
    13. REESE EA; KHANDELWAL M; WU YK; BORENSTEIN M
      DIETARY-INTAKE OF MYOINOSITOL AND NEURAL-TUBE DEFECTS IN OFFSPRING OFDIABETIC RATS

      American journal of obstetrics and gynecology
    14. XUE YZ; BORENSTEIN M; COOPER S; TZENG TB
      ABSORPTION KINETICS OF DICLOFENAC IN DENTAL PATIENTS AFTER MOLAR

      Clinical pharmacology and therapeutics
    15. CHAKOS MH; ALVIR JMJ; WOERNER MG; KOREEN A; GEISLER S; MAYERHOFF D; SOBEL S; KANE JM; BORENSTEIN M; LIEBERMAN JA
      INCIDENCE AND CORRELATES OF TARDIVE-DYSKINESIA IN FIRST EPISODE OF SCHIZOPHRENIA

      Archives of general psychiatry
    16. SIVAN E; REECE EA; WU YK; HOMKO CJ; POLANSKY M; BORENSTEIN M
      DIETARY VITAMIN-E PROPHYLAXIS AND DIABETIC EMBRYOPATHY - MORPHOLOGIC AND BIOCHEMICAL-ANALYSIS

      American journal of obstetrics and gynecology
    17. REECE EA; WU YK; WIZNITZER A; HOMKO C; YAO J; BORENSTEIN M; SLOSKEY G
      DIETARY POLYUNSATURATED FATTY-ACID PREVENTS MALFORMATIONS IN OFFSPRING OF DIABETIC RATS

      American journal of obstetrics and gynecology
    18. SACKSTEIN R; BORENSTEIN M
      THE EFFECTS OF CORTICOSTEROIDS ON LYMPHOCYTE RECIRCULATION IN HUMANS - ANALYSIS OF THE MECHANISM OF IMPAIRED LYMPHOCYTE MIGRATION TO LYMPH-NODE FOLLOWING METHYLPREDNISOLONE ADMINISTRATION

      Journal of investigative medicine
    19. AKSOY MO; BORENSTEIN M; LI XX; KELSEN SG
      EICOSANOID PRODUCTION IN RABBIT TRACHEAL EPITHELIUM BY ADENINE-NUCLEOTIDES - MEDIATION BY P-2-PURINOCEPTORS

      American journal of respiratory cell and molecular biology
    20. SCHOOLER N; KANE J; MARDER S; BAKER R; SAFFERMAN A; WIRSHING W; AMES D; GANGULI R; UMBRICHT D; BORENSTEIN M
      EFFICACY OF CLOZAPINE VS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL - PRELIMINARY FINDINGS

      Schizophrenia research
    21. ROSSOFF LJ; BORENSTEIN M; ISENBERG HD
      IS HAND-WASHING REALLY NEEDED IN AN INTENSIVE-CARE UNIT

      Critical care medicine
    22. POLLACK S; LIEBERMAN JA; FLEISCHHACKER WW; BORENSTEIN M; SAFFERMAN AZ; HUMMER M; KURZ M
      A COMPARISON OF EUROPEAN AND AMERICAN DOSING REGIMENS OF SCHIZOPHRENIC-PATIENTS ON CLOZAPINE - EFFICACY AND SIDE-EFFECTS

      Psychopharmacology bulletin
    23. AMES D; WIRSHING WC; KANE J; SCHOOLER N; MARDER SR; BAKER R; SAFFERMAN A; GANGULI R; UMBRICHT D; BORENSTEIN M
      EFFICACY OF CLOZAPINE VS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL - PRELIMINARY-RESULTS

      Biological psychiatry
    24. KANE J; WOERNER M; BORENSTEIN M
      TARDIVE-DYSKINESIA INCIDENCE AND OUTCOME

      Schizophrenia research
    25. BORENSTEIN M
      PLANNING FOR PRECISION IN SURVIVAL STUDIES

      Journal of clinical epidemiology
    26. BORENSTEIN M
      SIMULATION OF COMPLEX SURVIVAL DISTRIBUTIONS

      Behavior research methods, instruments, & computers
    27. DODDI S; RIFKIN A; KARAJGI B; COOPER T; BORENSTEIN M
      BLOOD-LEVELS OF HALOPERIDOL AND CLINICAL OUTCOME IN SCHIZOPHRENIA

      Journal of clinical psychopharmacology
    28. BORENSTEIN M
      THE CASE FOR CONFIDENCE-INTERVALS IN CONTROLLED CLINICAL-TRIALS

      Controlled clinical trials
    29. POLLACK S; BRUCE P; BORENSTEIN M; LIEBERMAN J
      THE RESAMPLING METHOD OF STATISTICAL-ANALYSIS

      Psychopharmacology bulletin
    30. POLLACK S; BRUCE P; BORENSTEIN M; LIEBERMAN J
      THE RESAMPLING METHOD OF STATISTICAL-ANALYSIS

      Psychopharmacology bulletin
    31. BORENSTEIN M
      A NOTE ON THE USE OF CONFIDENCE-INTERVALS IN PSYCHIATRIC RESEARCH

      Psychopharmacology bulletin
    32. BORENSTEIN M
      A NOTE ON THE USE OF CONFIDENCE-INTERVALS IN PSYCHIATRIC RESEARCH

      Psychopharmacology bulletin
    33. BORENSTEIN M; SHUPAK RC; BARNETTE RE; COONEY GF; TZENG TB
      CARDIOVASCULAR EFFECTS OF DIFFERENT INFUSION RATE OF SUFENTANIL (S) IN PATIENTS UNDERGOING CORONARY SURGERY (CS)

      Clinical pharmacology and therapeutics
    34. RIFKIN A; DODDI S; KARAJGI B; BORENSTEIN M; MUNNE R
      DOSAGE OF HALOPERIDOL FOR MANIA

      British Journal of Psychiatry
    35. MAYERHOFF DI; LOEBEL AD; ALVIR JMJ; SZYMANSKI SR; GEISLER SH; BORENSTEIN M; LIEBERMAN JA
      THE DEFICIT STATE IN FIRST-EPISODE SCHIZOPHRENIA

      The American journal of psychiatry
    36. CHAKOS MH; LIEBERMAN JA; BILDER RM; BORENSTEIN M; LERNER G; BOGERTS B; WU HW; KINON B; ASHTARI M
      INCREASE IN CAUDATE NUCLEI VOLUMES OF FIRST-EPISODE SCHIZOPHRENIC-PATIENTS TAKING ANTIPSYCHOTIC-DRUGS

      The American journal of psychiatry
    37. POLLACK S; LIEBERMAN J; KLEINER D; SZYMANSKI S; KANE J; BORENSTEIN M; COOPER T
      HIGH PLASMA CLOZAPINE LEVELS IN TARDIVE-DYSKINESIA

      Psychopharmacology bulletin
    38. LIEBERMAN J; JODY D; GEISLER S; ALVIR J; LOEBEL A; SZYMANSKI S; WOERNER M; BORENSTEIN M
      TIME-COURSE AND BIOLOGIC CORRELATES OF TREATMENT RESPONSE IN 1ST-EPISODE SCHIZOPHRENIA

      Archives of general psychiatry
    39. ROSSOFF LJ; LAM S; HILTON E; BORENSTEIN M; ISENBERG HD
      IS THE USE OF BOXED GLOVES IN AN INTENSIVE-CARE UNIT SAFE

      The American journal of medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 20:06:40